Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Malaria Biomarkers Detected In Human Breath

By LabMedica International staff writers
Posted on 13 Apr 2015
The majority of diagnoses of malaria rely on a combination of clinical presentation and visualizing parasites in a stained blood film or by performing a rapid diagnostic test.

Human breath offers an attractive alternative to blood as the basis for simple, non-invasive diagnosis of infectious disease, and when breath samples were taken during controlled human malaria infection specific malaria associated volatiles could be detected in human breath.

Scientists at the Commonwealth Scientific and Industrial Research Organization (CSIRO) (Dickson, Australia) and their colleagues collected breath samples from volunteers that had been infected with the malaria parasite Plasmodium falciparum, who were enrolled in a drug trial. More...
The volunteers breathed through a cardboard tube into a chamber connected to a connected to a 3‐L impermeable aluminum gas bag (Shanghai Sunrise Instrument Co.; Shanghai, China).

Exhaled breath analysis was carried out by gas chromatography-mass spectrometry. The gas chromatograph 451 Model GC (Bruker Daltonik Inc.; Billerica, MA, USA) was used and the Bruker Daltonik Scion SQ single quadrupole mass was set with a full scan detection. Real-time polymerase chain reactions and cell cultures were also performed.

The team identified nine compounds whose concentrations varied significantly over the course of malaria infection: carbon dioxide, isoprene, acetone, benzene, cyclohexanone and four thioethers. The latter group: allyl methyl sulfide, 1-methylthio-propane, (Z)-1-methylthio-1-propene and (E)-1-methylthio-1-propene had not previously been associated with any disease condition.

Before antimalarial-drug treatment, there was evidence of concurrent 48 hour-cyclical changes in both the levels of thioethers and parasitemia. Phase-shifting the values for thioether concentrations by 24 hours, revealed a direct correlation between the parasitemia and volatile levels. Volatile levels declined monotonically at around 6.5 hours after initial drug treatment, correlating with clearance of parasitemia. The study was published online on March 25, 2015, in the Journal of Infectious Diseases.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Shanghai Sunrise Instrument Co.
Bruker Daltonik Inc.


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.